Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...
Activation of the serotonin receptor, 5-HT1A, has been shown to regulate mood and cognition. The receptor is the primary target of buspirone, vilazodone, and gepirone, FDA-approved medications for the ...
News-Medical.Net on MSN
UC Davis team creates new class of serotonin-effecting drugs
UC Davis researchers have developed a new method that uses light to transform amino acids - the building blocks of proteins - ...
In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers at the Icahn School of Medicine at Mount Sinai have developed new insights ...
Hosted on MSN
Neuroscientists just rewrote our understanding of psychedelics with a groundbreaking receptor-mapping study
Classical psychedelics act on a surprisingly broad range of brain receptors, not just the serotonin receptor long associated with their hallucinogenic effects, according to new research published in ...
Source: By IndependentOo, Dominik from Germany, Maximilian IV, Laitche, NASA; composite artwork by Belbury - CC BY 4.0, Wikimedia Working in his lab at the pharmaceutical company Sandoz in 1938, ...
A study published in the British Journal of Pharmacology last month explored how ayahuasca (shortened to AYA for the use in this study) and DMT interacts with serotonin receptors in the part of the ...
Researchers at Baylor College of Medicine, the University of Cambridge in the U.K. and collaborating institutions have shown that serotonin 2C receptor in the brain regulates memory in people and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results